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N-terminal acetylation is a major and vital protein
modification catalyzed by N-terminal acetyltrans-
ferases (NATs). NatF, or Na-acetyltransferase 60
(Naa60), was recently identified as a NAT in multicel-
lular eukaryotes. Here, we find that Naa60 differs
from all other known NATs by its Golgi localization.
A new membrane topology assay named PROMPT
and a selective membrane permeabilization assay
established that Naa60 faces the cytosolic side of
intracellular membranes. An Nt-acetylome analysis
of NAA60-knockdown cells revealed that Naa60, as
opposed to other NATs, specifically acetylates trans-
membraneproteins andhasapreference forN termini
facing the cytosol. Moreover, NAA60 knockdown
causes Golgi fragmentation, indicating an important
role in themaintenance of theGolgi’s structural integ-
rity. This work identifies a NAT associated with mem-
branous compartments and establishes N-terminal
acetylation as a common modification among trans-
membrane proteins, a thus-far poorly characterized
part of the N-terminal acetylome.
INTRODUCTION
N-terminal acetyltransferases (NATs) belong to a family of en-
zymes containing a Gcn5-related N-acetyltransferase (GNAT)
fold. The NATs transfer an acetyl group from acetyl coenzyme
A (Ac-CoA) to the a-amino group of substrate protein N termini.
NATs are distinguished from each other by their subunit com-
position (designated Na-acetyltransferases, or Naas), and the
type of N termini they acetylate—in particular the first two resi-
dues—are of importance (Starheim et al., 2012). A wide range
of functional effects of the N-terminal (Nt) acetyl group have
been shown for a selection of NAT-modified proteins (Arnesen,1362 Cell Reports 10, 1362–1374, March 3, 2015 ª2015 The Authors2011). Although the overall biological function of this ubiquitous
and cotranslational process has been difficult to pinpoint,
several reports suggest its impact on protein subcellular locali-
zation (Behnia et al., 2007; Behnia et al., 2004; Murthi and Hop-
per, 2005; Setty et al., 2004), protein lifetime/degradation
(Hwang et al., 2010; Shemorry et al., 2013), and protein-protein
interactions (Monda et al., 2013; Scott et al., 2011).
NatF (Naa60) is the most recently identified member of the
NAT family and was shown to be conserved among multicellular
eukaryotes while absent from unicellular eukaryotes such as
yeast (Van Damme et al., 2011b). NatF contributes to an evolu-
tionary shift toward increased N-terminal acetylation (Nt-acety-
lation), as demonstrated by additional substrate Nt-acetylation
in yeast ectopically expressing hNaa60 (Van Damme et al.,
2011b). Thus, it seems that Naa60 is capable of operating
independently, and no additional subunits have been described
for NatF. N termini recognized by NatF include those starting
with Met-Lys as well as other Met-starting N termini, preferen-
tially those followed by a hydrophobic amino acid (Van Damme
et al., 2011b). Previously, these N termini were thought to
be acetylated by NatC (Naa30) (Polevoda et al., 1999; Starheim
et al., 2009) and NatE (Naa50) (Evjenth et al., 2009; Van Damme
et al., 2011a). As such, the addition of NatF to the NAT
family revealed some potential redundancy among these three
enzymes.
Depletion of NAA60 in Drosophila Dmel2 cells results in
abnormal chromosome segregation during anaphase (Van
Damme et al., 2011b), a phenotype similar to that of NAA50-
depleted cells (Hou et al., 2007; Pimenta-Marques et al., 2008;
Williams et al., 2003). A Drosophila genetic screen implied an
important physiological role for Naa60 related to neural func-
tioning, possibly linking Naa60 to infantile neuronal ceroid lipo-
fuscinosis (Buff et al., 2007). It has not been determined how
these cellular and physiological phenotypes may be manifested
through protein-substrate effects that may occur in the absence
of NatF-mediated Nt-acetylation.
The eukaryotic NATs NatA–E are all cytosolic and interact
with ribosomes either via an auxiliary subunit (Gautschi et al.,
Figure 1. Naa60 Associates with Organelles
as Opposed to the Other Known Human
Na-Acetyltransferases and Co-distributes
with Markers of the Golgi Apparatus
(A) Subcellular localization of all known human
Naas. HeLa cells expressing C-terminally V5-tag-
ged Naa10, Naa11, Naa20, Naa30, Naa40, Naa50,
and Naa60 were subjected to immunocytochem-
istry. Only Naa60 showed localization to intracel-
lular membranous compartments other than the
nucleus.
(B) Naa60-V5 expressing HeLa cells were co-
immunostained with anti-V5 and anti-GM130.
Low-Naa60-V5-expressing cells are shown.
(C) HeLa cells were treated with brefeldin A (BFA)
and co-immunostained with anti-Naa603-77 and
antibodies toward the cis/medial-Golgi marker
Giantin. As for Giantin, the perinuclear Golgi signal
of Naa60 was lost after BFA treatment.
Scale bars, 10 mm. See also Figures S1 and S3A.2003; Starheim et al., 2012) or, as in the case of NatD (consisting
only of Naa40), directly (Hole et al., 2011; Polevoda et al., 2009).
Studies of substrate Nt-acetylation have primarily focused on
cytosolic and soluble proteins, and it has been shown that a
majority of soluble yeast (>50%) and human (>80%) proteins
are subjected to this modification (Arnesen et al., 2009). So far,
the possibility and biological significance of Nt-acetylation of
membrane proteins has been much less described, in part
because no organelle-associated NAT has been identified.
Here, we describe the newly identified Naa60 as the first
organellar NAT and establish its membranous association
with the Golgi complex. We aimed to characterize the topologyCell Reports 10, 1362–137of its active site as well as the substrates
of Naa60-mediated Nt-acetylation. By
knocking down NAA60, we identified a
Golgi structural phenotype and identified
several organellar substrates, thus indi-
cating a necessity for Naa60-mediated
Nt-acetylation in the maintenance of the
Golgi architecture and enlightening a
thus-far poorly characterized part of the
Nt acetylome.
RESULTS
Naa60 Differs from the Other
Known Na-Acetyltransferases by
Its Golgi Localization
The subcellular distribution of all known
human catalytic Na-acetyltransferases
(Naas) was investigated in HeLa cells
expressing these proteins with a C-termi-
nal V5 tag. Naa60 distributed in a
typical organellar localization pattern,
as opposed to Naa10, Naa11, Naa20,
Naa30, Naa40, and Naa50, which all
showed cytoplasmic and nuclear locali-
zations (Figure 1A).
Co-localization analyses showed that Naa60-V5 co-distrib-
uted with the cis-Golgi marker GM130 (Figure 1B). The endoge-
nous Naa60 also co-distributed with the cis/medial-Golgi protein
Giantin (Figure 1C, upper). Additional evidence for Naa60’s Golgi
residency was shown by its sensitivity to the Golgi-disrupting
drug brefeldin A (Klausner et al., 1992), which disrupted the peri-
nuclear staining of Naa60 (Figure 1C, lower).
In addition to the Golgi structure, both overexpressed and
endogenous Naa60 were found in vesicles spread throughout
the cell. These vesicles weakly co-localized withmarkers for per-
oxisomes (PMP70), endosomes (EEA1), lysosomes (LAMP1),
and secretory vesicles (HSA, Secretogranin II). In addition,4, March 3, 2015 ª2015 The Authors 1363
Figure 2. TheNaa60CTerminus Is Required
and Sufficient for Membrane Localization
and Integration
(A) The Naa60 protein sequence with predicted
motifs and domains indicated. Dark purple,
transmembrane domains (predicted with low
probability); blue underlined, regions unique for
Naa60 among the catalytic Naas (aa 1–13, 78–87,
and 180–242); red underlined, putative endo/
lysosomal targeting signal, QAHSLL (aa 216–221);
C207 and C222 were predicted as putative S-
palmitoylation sites by CCS-Palm 3.0. The primary
sequence constituting the GNAT-domain together
with the core of the Ac-CoA-binding motif Q/
RxxGxG/A is indicated above.
(B) Naa60 constructs used for localization studies.
Color-coding as in (A).
(C) HeLa cells were transfected with the indicated
constructs and fixed. The membrane localization
observed for the full-length Naa60 (Naa601–242)
was lost by deleting the last 58 amino acids
(Naa601–184). eGFP-Naa60182–242 showed a
localization pattern resembling that of full-length
C-terminally tagged Naa60 whereas a shorter
construct, eGFP-Naa60217–242 localized to the
cytosol and nucleus. Naa601–242 and Naa601–184
were expressed from plasmid without tag and
detected with anti Naa603–77. Scale bar, 10 mm.
See also Figure S2.
(D) HeLa cells expressing untagged Naa60 were
subjected to subcellular fractionation yielding an
organellar pellet (P1), which was dissolved in
either sucrose buffer (pH 7.4) or sodium carbonate
buffer (pH 11.5) prior to a second centrifugation
yielding two sets of P2s and S2s. Naa60 shared its
western blot profile with the non-extractable inte-
gral membrane proteins Calnexin and RCAS1, as
opposed to the peripheral membrane protein
GM130, which was extractable by the alkaline
buffer.overexpressed Naa60-tGFP was observed to co-distribute well
with the ER marker PDI (Figure S1).
Naa60 Localization Depends on a C-Terminal
Membrane-Integrating Region
To investigate whether Naa60 contains targeting signals respon-
sible for its distinct organellar localization, we identified specific
regions unique for Naa60 among the catalytic Naas. The cata-
lytic subunits Naa30 and Naa50 that have overlapping substrate
specificities with Naa60 are also phylogenetically most closely
related. Recently, the crystal structure of Naa50 was resolved,
thereby providing a compatible reference for Naa60 (Liszczak
et al., 2011). By using published alignments (Van Damme et al.,
2011b) and comparing those to the Naa50 structure (Liszczak
et al., 2011), we found three regions of potential interest (indi-
cated in blue in Figure 2A): (1) the first 13 amino acids (aa) in
the N terminus, potentially serving as an N-terminal targeting
sequence; (2) aa 78–87, an extended sequence located between
the region corresponding to b strands 3 and 4 in the Naa50 struc-
ture (Liszczak et al., 2011), predicted as an extended loop; and
(3) aa 180–242 at the C terminus, representing an extension1364 Cell Reports 10, 1362–1374, March 3, 2015 ª2015 The Authorsonly present in Naa60. The latter also contains a predicted
putative di-leucine endo/lysosomal-targeting signal QAHSLL
(aa 216–221) (by Eukaryotic Linear Motif [ELM]), highlighted in
red in Figure 2A. Furthermore, the C-terminal region contained
two putative transmembrane domains (TMDs) in regions 193–
213 and 217–236 predicted with a low probability (by TMpred,
TopPred, PRODIV PRO, and MEMSAT3). We also found two pu-
tative S-palmitoylation sites on C207 and C222 (by CCS-Palm
3.0). Of note, other weak transmembrane predictions were
found for regions around 52–69 (by TMpred, TMHMM, PRO
DIVPRO, SCAMPI-msa, OCTOPUS, TOPCONS, and MEMSAT-
SVM) and 84–104 (by TMpred and TopPred), but these were
considered unlikely, since they comprise part of the predicted
GNAT domain and align to b strands 3 and 4 of Naa50 (Liszczak
et al., 2011) and Naa10 (Liszczak et al., 2013). Examining Naa50
with several TM databases revealed that these areas could be
misread as potential transmembrane regions, likely owing to
the fact that GNATs in general have several hydrophobic interac-
tions in these structural domains (Dyda et al., 2000).
Based on these predictions, we made truncation and
deletion mutants (Figure 2B) and investigated their subcellular
localization (Figures 2C and S2). A Naa60 variant lacking the last
58 aa (Naa601–184) lost membrane localization (Figure 2C), indi-
cating that the C-terminal region is required for the correct sub-
cellular targeting of Naa60. Interestingly, this C-terminal region
of aa 185–242 comprises the predicted transmembrane do-
mains TMD3 and 4 (Figures 2A and 2B). Next, we tested whether
this part of Naa60’s C terminus was sufficient to target eGFP to
the same localization as the full-length Naa60. As shown in Fig-
ure 2C (eGFP-Naa60182–242), this was indeed the case. Using
the same approach, we also tested a shorter part of the Naa60
C terminus (eGFP-Naa60217–242), thereby omitting the fourth pre-
dicted TMD, but not the third. These last 26 aa of Naa60were not
sufficient to provide an organellar localization pattern when
added to the C terminus of eGFP.
To further elucidate how Naa60’s C terminus is implicated in
membrane localization, we subjected Naa60-expressing cells
to subcellular fractionation followed by carbonate extraction.
As shown in Figure 2D, Naa60 was resistant to carbonate
washing of membranes, similar to the integral membrane pro-
teins RCAS1 and Calnexin, and as opposed to the peripheral
membrane protein GM130, hence suggesting that the two puta-
tive TMDs in Naa60’s C terminus are membrane integrated.
The other unique regions of the Naa60 sequence (Figure 2A)
did not appear to be important for Naa60membrane localization.
An N-terminally truncated Naa60 variant as well as N-terminally
tagged Naa60 showed altered localization patterns but retained
membrane association (Figure S2A). Deletion of the regions
aa 78–87 and aa 216–221 as well as mutation of leucine 220
and 221 to alanine did not affect the subcellular localization of
Naa60 (Figure S2B). Furthermore, simultaneous Cys to Ser
mutations of all five of Naa60’s cysteines (Figure S2C) did not
abolish Naa60 membrane localization, thus making S-palmitoy-
lation unlikely to be a major determinant for Naa60’s organ-
ellar localization. Additionally, 2-bromo palmitate (2-BP) did not
disrupt Naa60 membrane association, although the subcellular
localization pattern was somewhat affected (Figure S2D), likely
due to indirect effects of this general palmitoylation inhibitor.
PROMPT Assay for Determining C-Terminal Membrane
Topology of Naa60
Since our Naa60 truncations indicated the importance of the C
terminus in the subcellular targeting of Naa60 and the carbonate
extraction experiments suggested its membrane integration, we
further addressed the intracellular membrane topology of the C
terminus. A proteolysis-based assay, named PROMPT (PROte-
ase assay for Membrane Protein Topology), was developed to
determine the topology of protein C termini. The protein of inter-
est is fused at its C terminus to a double-fluorescent tag of eGFP
and mCherry (Figure 3A). These two tags are linked via recogni-
tion sites (rs) of two proteases. One recognition site is specific
for the endogenous protease Furin, which resides in the Golgi
lumen, and the other is specific for the protease VP24 from her-
pes simplex virus and can be expressed in the cytosol by
co-transfection. If the C terminus of the protein of interest, and
hence the double tag, faces the Golgi lumen, then Furin action
will cause separation of the mCherry part from the rest of the
fusion protein. The concomitant reduction of the molecular
weight (MW) of the protein by 27 kDa can be detected by immu-Cenoblot analysis. For plasma membrane proteins that are trans-
ported through the Golgi complex, Furin-mediated cleavage
can be visualized by fluorescence microscopy, leading in the
abovementioned case to an accumulation of green fluorescence
at the plasma membrane, whereas the red fluorescence is left in
the Golgi. If the C terminus of the protein faces the cytosol, Furin
action on the fusion protein cannot occur, causing co-localization
of green and red fluorescence throughout the secretory pathway.
In this case, cleavage by the co-expressed cytosolic viral prote-
ase VP24 can confirm cytosolic topology of the C terminus.
The glycosylated transmembrane proteins CD38 (type II) and
CD4 (type I) were used for validation of the PROMPT assay (Fig-
ures 3B–3D). As shown by fluorescence microscopy (Figure 3B)
and immunoblot analysis (Figure 3C), the CD38-PROMPT
construct was subject to Furin-mediated cleavage in the pres-
ence of an intact Furin recognition site. Cleavage of the CD38
construct did not occur in a Furin-rs-negative context (i.e., in
the presence of a non-cleavable, mutated Furin recognition
site [CD38-PROMPT (F-)]) or in the presence of the co-expressed
VP24. In contrast, expression of the CD4-PROMPT construct re-
sulted in a persistent co-localization of the fluorescent reporter
proteins (Figure 3B), and cleavage of the mCherry portion from
the CD4-PROMPT construct occurred in the cytosol upon co-
expression with cytosolic VP24 (Figure 3D).
We next used the PROMPT assay to investigate the topology
of Naa60’s C terminus. Expression of NAA60-PROMPT in 293
cells resulted in a persistent co-localization of the green and
red fluorescence (Figure 3E, upper). In contrast, co-expression
of cytosolic VP24 released the mCherry portion into the cyto-
plasm (Figure 3E, lower). That is, the cytosolic VP24, but not
the Golgi-localized Furin, had access to the recognition site,
indicating that the C terminus of Naa60 faces the cytosol. These
data were further confirmed by immunoblot analysis. The MW
band pattern of the NAA60-PROMPT construct did not differ
from that of the NAA60-construct in a Furin-rs-negative context
(NAA60-PROMPT [F-]). Expression of the NAA60-construct
along with the cytosolic VP24 in a Furin-rs-negative context re-
sulted in amass reduction of the fusion protein of27 kDa owing
to VP24-mediated cleavage of the mCherry portion.
SelectiveMembrane Permeabilization: Naa60 Faces the
Cytosol
To further substantiate the results from the PROMPT assay and
to additionally test other regions of Naa60, we made use of a se-
lective membrane permeabilization immunofluorescence assay.
Cells were either fully permeabilized with Triton X-100 or the
plasma membrane was selectively permeabilized with digitonin.
Antibodies toward PDI (ER, lumenal) and Calnexin (ER, C-termi-
nal cytosolic epitope) served as controls to monitor the degree
of membrane permeabilization. As seen in Figure 4, panel 1,
Calnexin was immunodetected with both permeabilization
detergents, whereas the PDI signal was clearly absent in digi-
tonin-permeabilized cells.
The C and N termini of Naa60 were investigated by using ter-
minal-tagged Naa60 constructs, Naa60-V5 and eGFP-Naa60,
respectively. Naa60-V5 was readily detected by anti-V5 in the
digitonin-permeabilized cells in which the PDI signal was lacking
(Figure 4, panel 2), thus confirming the Naa60 C-in topologyll Reports 10, 1362–1374, March 3, 2015 ª2015 The Authors 1365
Figure 3. PROtease Assay for Membrane
Protein Topology, or PROMPT
(A) Principle and constructs of PROMPT. The
protein of interest (POI) is expressed with a
C-terminal double-fluorescent reporter tag com-
posed of eGFP (green) and mCherry (red).
PROMPT determines the membrane topology of
the POI by organelle-specific proteolytic cleavage
of the red fluorescent portion from the PROMPT
construct. The endogenous Golgi-localized pro-
tease, Furin, will find its recognition site (rs) when
the POI C terminus faces the Golgi (left), whereas
the ectopic-expressed VP24 will cleave PROMPT
constructs when the C terminus of the POI is
cytosolic (right). Controls include experiments
performed in the absence of VP24 or with a POI
construct harboring a mutated Furin recognition
site.
(B–D) Validation of PROMPT assay. HeLa S3 (B) or
293 cells (C and D) expressing the indicated con-
structs were fixed and subjected to fluorescence
microscopy (B) or harvested for western blotting
(C and D). Furin-mediated cleavage occurred on
the CD38-construct only in the presence of an
intact Furin recognition site (B and C). The CD4
construct was cleaved not by Furin but by the co-
expressed cytosolic VP24 (B and D).
(E and F) Determination of Naa60’s C-terminal
topology by the PROMPT assay. NAA60 was
subcloned into the PROMPT constructs shown in
(A) and expressed in 293 cells, which were fixed
and subjected to fluorescence microscopy (E) or
western blotting (F). The Naa60 construct was
subject to cleavage not by Furin but by the co-
expressed cytosolic VP24.
Scale bars, 20 mm (B) and 10 mm (E). rs, recognition
site; Mut., mutated; -PROMPT, POI-eGFP-[VP24
rs]-[Furin rs]-mCherry; -PROMPT (F-), POI-eGFP-
[VP24 rs]-[Mut. Furin rs]-mCherry; filled arrow,
intact fusion protein; framed arrow, cleaved fusion
protein.determined by PROMPT. eGFP-Naa60 was also detected by
anti-GFP visualized by red secondary antibody in the digitonin-
permeabilized cells (Figure 4, panel 3), thus demonstrating
that the amino end of Naa60 also faces the cytosol. The same
was observed for the N-truncated eGFP-Naa60 variant, eGFP-
Naa60182–242, indicative of amino acid 182’s cytosolic residence.1366 Cell Reports 10, 1362–1374, March 3, 2015 ª2015 The AuthorsFurthermore, several antibodies
directed toward specific peptide seq-
uence epitopes of Naa60 were applied
in order to investigate the topology of
various parts of the Naa60 protein. Since
the endogenous Naa60 signal is very
weak, thus representing a challenge in
this assay, we used these antibodies to
detect Naa60-V5 or -FLAG. The three an-
tibodies that successfully recognized
overexpressed Naa60 (anti-Naa603–77,
anti-Naa6069–82, and anti-Naa60192–241;
Figure 4, panels 5–7) were used to deter-mine the topology of these regions. All these antibodies pro-
duced specific signals in the digitonin-treated samples, thus
determining the cytosolic residency of their respective regions.
Of specific importance is that aa 69–82, which are at the core
of Naa60’s GNAT fold (refer to Figure 2A), were detected on
the cytosolic side of the intracellular membranes. In summary,
Figure 4. Naa60 Faces the Cytosol
HeLa cells were subjected to selective membrane
permeabilization immunofluorescence. All probed
regions of Naa60 were mapped to the cytosolic
side: panel 2, C-terminally tagged Naa60-V5 de-
tected with anti-V5; panel 3, N-terminally tagged
eGFP-Naa60 detected with anti-GFP; panel 4,
Naa60 amino acid 182 detected with antibody
toward N-terminal tag on truncated NAA60 (eGFP
Naa60182–242); panel 5, Naa60 aa 3–77 detected
with antibody toward Naa60 peptide sequence 3–
77; panel 6, Naa60 aa 69–82 detected with anti-
body toward Naa60 peptide sequence 69–82; and
panel 7, Naa60 aa 192–241 detected with anti-
body toward Naa60 peptide sequence 192–241.
Lumenal PDI and cytosolic Calnexin controls
(panel 1) were performed in all experiments. In
addition, the PDI control was applied in all cells
where this combination of antibodies and/or fluo-
rophores was compatible. Scale bar, 10 mm.we found all the tested parts of Naa60 to reside at the cytosolic
side of intracellular membranes.
The Organellar Nt-Acetylome: Naa60 Nt-Acetylates
Transmembrane Proteins
Given the unique localization of Naa60, we wondered about
the subcellular localization of its substrates. In order to identifyCell Reports 10, 1362–137potential organellar substrates of Naa60,
we performed crude fractionation of
stable isotope labeling by amino acids
in cell culture (SILAC)-labeled NAA60
knockdown and control A-431 cells (Fig-
ures S3A and S3B) and analyzed both
cytosolic and organellar fractions by dif-
ferential N-terminal combined fractional
diagonal chromatography (COFRADIC).
Differential proteome analyses of soluble
and insoluble extracts of control small
interfering RNA (siCTRL)- and siNAA60-
treated cells resulted in the identification
of 1,699 unique N termini, i.e., N-termini
originating from 1,537 unique proteins,
including those of 208 (13%) transmem-
brane proteins (Table S1) and 23 potential
Naa60 substrates (Table 1; Figure S3C).
Interestingly, given the organellar locali-
zation of Naa60, all the substrates were
identified in the organellar fraction and
21 out of the 23 substrates are estab-
lished and/or predicted transmembrane
proteins. Furthermore, among these
transmembrane substrate proteins, there
was a clear overrepresentation of N-in
topology, which corresponds with the
topology of Naa60 established above
(Figures 3 and 4). Of note however, iden-
tified Naa60 substrates covered a variety
of membrane compartments (Table 1;ER, plasma membrane, Golgi apparatus, mitochondria, and ve-
sicular membranes), even though Naa60 mainly resides at the
Golgi.
Almost all identified Naa60 substrates matched the previously
determined Naa60 substrate specificity (Van Damme et al.,
2011b) and recombinant Naa60-acetylated corresponding pep-
tide sequences in vitro (MVSM and MKQY peptides; Figure S3D),4, March 3, 2015 ª2015 The Authors 1367
Table 1. Naa60 Substrates Identified in the COFRADIC Analysis of Fractionated siCTRL and siNAA60 A-431 Cells
Nt Sequence Start
Nt-Ac
siCTRL (%)
Nt-Ac
siNAA60 (%) D Nt-Ac (%) Protein Full Protein Name Annotated TM (Predicted) TMD
N-Term
Topology
Subcellular
Localizations
MAPKG 1 87 16 71 TRAPga translocon-associated protein subunit gamma O 4 in ER-M
MKQYQ 34 79 25 54 TM222 transmembrane protein 222 O 3 in PM
MGPGPb 1 71 20 51 MFSD12a major facilitator superfamily domain-
containing protein 12
O 9/9+(1) out/in ER-M
MVSMS 1 85 42 43 LAPTM4Aa lysosomal-associated transmembrane
protein 4A
O 4 in ES
MVISE 1 76 38 38 UfSP2a Ufm1-specific protease 2 1 in Cyto, ER
MQGKK 1 66 29 37 OATP3Aa solute carrier organic anion transporter family
member 3A1
O 12/12+(1)/
12+(1)/12+(2)
in PM
MAPKG 1 94 60 34 TM208a transmembrane protein 208 O 2 in ER-M
MLAAKb 26 70 39 31 LAT1 large neutral amino acids transporter small
subunit 1
O 12/12+(1) in C; APM
MLPST 1 100 72 28 UNC50 protein unc-50 homolog O 5 in NIM; GA-M
MAPDP 1 95 69 26 FADS1 Fatty acid desaturase 1 O 3 in ER-M
MKAVQ 148 88 64 24 LRC59 leucine-rich repeat-containing protein 59 O 1 out MI M; ER-M
MVGFG 1 90 68 22 CASC4 protein CASC4 O 1 in M
AAGGSc 2 80 62 18 GSCR2 glioma tumor suppressor candidate region
gene 2 protein
no — NU; NO
MIEES 1 79 62 18 DTN-B dystrobrevin beta (1) out C
AANYS 2 75 58 17 TMM43 transmembrane protein 43 O 3/3+(1) in ER; NIM
MGELP 1 65 49 17 SFXN3 sideroflexin-3 O 4/4+(1) out/in Mito-M
MTQGK 1 96 82 14 HIAT1 hippocampus abundant transcript 1 protein O 11 in M
MYAPG 1 97 85 12 TM127 transmembrane protein 127 O 4 in PM; C
MMGLG 1 95 83 11 GOLM1 Golgi membrane protein 1 O 1 in GA; cis-GA-M
AATALc 2 61 50 11 PTPM1 phosphatidylglycerophosphatase and
protein-tyrosine phosphatase 1
no — MIM
MVSKA 1 14 3 11 UXS1 UDP-glucuronic acid decarboxylase 1 O 1 in GA-M
AAVAA 2 33 22 10 HACD2 very-long-chain (3R)-3-hydroxyacyl-[acyl-carrier
protein] dehydratase 2
O 9/4+(1) in/out ER-M
MAPMG 1 8 0 8 IMP3 inositol monophosphatase 3 O 1/1+(1)/1+(2) in M
See also Table S1 for a complete list of all N termini identified. Abbreviations: DNt-Ac, difference in degree of Nt-acetylation between siCTRL and siNAA60 samples; M, membrane; ES, endo-
membrane system; PM, plasma membrane; C, cytoplasm/cytosol; APM, apical membrane; NIM, nucleus inner membrane; GA, Golgi apparatus; MI, microsome; NU, nucleus; NO, nucleolus;
Mito, mitochondrion; MIM, mitochondrion inner membrane.
aSubstrates used in follow-up studies (Figure S3E).
bN termini whose mass spectrometry spectra are shown in Figure S3C.
cPossibly indirectly affected by NAA60 knockdown.
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Figure 5. The Naa60/NatF Substrate Cate-
gory Is Enriched for Transmembrane
Proteins
(A) All unique N termini identified in the siCTRL
setup, for which the degree of Nt-acetylation
could be determined, were grouped into trans-
membrane (TM) or non-transmembrane protein N-
termini (no TM) and categorized according their
NAT specificity profile. The ‘‘none’’ category con-
sists of (M)P- starting N termini that are typically
refractory to Nt-acetylation. The color code and
intensity reflects the average percentage of Nt
acetylation as determined in the siCTRL setup;
green and red coloring indicates a degree of Nt
acetylation above and below 50%, respectively.
(B) Venn diagrams of all N termini (left) and all
Naa60/NatF type N termini (right) for which the Nt-
acetylation status could be determined in both the
siCTRL and siNAA60 setups, grouped into trans-
membrane and non-transmembrane proteins.
(C) Bar chart plotting the occurrence of N termini
(i.e.: all Swiss-Prot N termini, all N termini identified
in this study, Naa60 substrate N termini identified
in this study, and Naa30 substrate N termini;
T.V.K., P.V.D., K.K.S., K.G., T.A., V. Jonckheere,
L.M. Myklebust, G. Bjørkøy, and J.E. Varhaug,
unpublished data) for non-transmembrane and
signal-containing proteins, non-transmembrane
proteins without signal sequence, transmembrane
and signal-containing proteins, and transmem-
brane proteins without signal sequence.indicative of the direct action of Naa60 toward these N termini
of transmembrane proteins. Note also that the only two affected
substrates not annotated or predicted to have amembrane span-
ning part (GSCR2 and PTPM1) did not display the canonical
Naa60/NatF substrate specificity (MX-); rather, alanine-alanine
(AA)and two further transmembraneNAA60-knockdown-affected
proteins (TMM43 and HACD2), also corresponded to AA-starting
proteins (Table 1). However, recombinant Naa60 did not signifi-
cantly Nt-acetylate this type of N terminus in vitro (AANY-peptide;
FigureS3D), indicating that these particular N termini are indirectly
affected byNAA60 knockdown rather than being true substrates.Cell Reports 10, 1362–137To further assess the enrichment of
transmembrane proteins as Naa60 sub-
strates, we first categorized all N termini
identified in the siCTRL setup into trans-
membrane (TM) or non-transmembrane
(no TM) proteins and found that the dis-
tribution of the NAT-substrate classes
differed between the two (Figure 5A).
More specifically, the occurrence of
NatC/F/E-type substrates is increased
in TM proteins at the expense of NatB-
type N termini. It is also noteworthy
that the average degree of Nt-acetyla-
tion is generally reduced among trans-
membrane as compared to non-trans-
membrane proteins (Figure 5A). This
observation is further exemplified bylooking at the differences in Nt-acetylation frequencies be-
tween TM and no TM proteins in sub-categories of NAT-sub-
strate classes, such as (M)T-starting N termini (Table S2). As
such, we here show for the first time at a proteome-wide scale
that Nt-acetylation is a frequent modification among human
transmembrane proteins (occurring on 82% of all identified
TM proteins), although generally to a lower degree as
compared to cytosolic proteins (Figure 5A; Table S2).
Next, identified Naa60 substrates were categorized into
TM and no-TM categories and their distribution related to
all Naa60/NatF-type and all N-termini identified (Figure 5B).4, March 3, 2015 ª2015 The Authors 1369
Considering only the sub-population of protein N termini that
matches the previously determined Naa60/NatF substrate pro-
file (Van Damme et al., 2011b) (Figure 5B, right), 67% of the po-
tential candidates (i.e., Nt-acetylated Naa60/NatF type N termini
in the siCTRL setup) were here identified as Naa60 substrates
based on their reduced degree of Nt-acetylation upon siNAA60
knockdown. The observation that Naa60 substrates were specif-
ically found among the category of transmembrane proteins was
found to be statistically significant as determined by a chi-square
test of independency (p < 0.001).
The fact that all Naa60 substrates were found in the organellar
fraction, while no substrates were detected uniquely in the cyto-
solic fraction, is in sharp contrast to similar knockdown Nt-ace-
tylome studies performed in human cells and targeting NatA
(Arnesen et al., 2009), NatB (Van Damme et al., 2012), or NatC
(T.V.K., P.V.D., K.K.S., K.G., T.A., V. Jonckheere, L.M. Mykle-
bust, G. Bjørkøy, and J.E. Varhaug, unpublished data). To sub-
stantiate Naa60’s preference for transmembrane proteins, we
plotted the distribution of all Swiss-Prot TM and no-TM proteins
(with and without signal sequences) versus the N termini identi-
fied in this study, Naa30 substrate N termini (T.V.K., P.V.D.,
K.K.S., K.G., T.A., V. Jonckheere, L.M. Myklebust, G. Bjørkøy,
and J.E. Varhaug, unpublished data), and Naa60 substrate N
termini identified in this study (Figure 5C). Noteworthy, there
was a significant enrichment of Naa60 substrates in the TM pro-
teins without signal sequence.
Six of the Naa60 substrates identified by means of N-terminal
COFRADIC (marked bold in Table 1) were tested for potential
Nt-acetylation-dependent effects on subcellular localization (Fig-
ure S3E). In order to study the potential Nt-acetylation depen-
dency of these substrate localizations, we applied the (X)PX-rule
(Goetze et al., 2009), stating that Nt-acetylation is prevented
when a proline occupies the first or second position. As such,
we constructed non-Nt-acetylatable versions of all six selected
C-terminally tGFP-tagged Naa60 substrates by introducing a
proline in their second position. All wild-type proteins and their
Pro mutant counterparts were investigated by fluorescence mi-
croscopy. Overall, no changes in subcellular localization for any
of the six substrates could be observed (Figure S3E). Based on
these results, it seems that Naa60-mediated Nt-acetylation is
not a major localization determinant for these substrates. How-
ever, even though the subcellular localization appeared unaf-
fected, we cannot exclude that these proteins could be
structurally or functionally impaired by the lack of Nt-acetylation.
NAA60 Knockdown Causes Golgi Fragmentation
Given Naa60’s localization to the Golgi and its activity toward
transmembrane proteins, we asked whether Naa60 could affect
Golgi structure. To this end, we looked at the localization pattern
of the cis-Golgi marker GM130 following small interfering
RNA (siRNA)-mediated knockdown of NAA60. We observed
the Golgi structure of siNAA60 cells to have a more fragmented
appearance (Figure 6A). Compared to siCTRL cells, a signifi-
cantly higher number of both HeLa and CAL-62 cells displayed
amore fragmented distribution of GM130 (Figure S4A). TheGolgi
is typically located at the perinuclear area around the microtu-
bule organizing center (Marie et al., 2009; Thyberg and Moska-
lewski, 1985). Here, we considered cells to display a fragmented1370 Cell Reports 10, 1362–1374, March 3, 2015 ª2015 The AuthorsGolgi phenotype when the distribution of GM130 was more
punctuated and expanded further away from the nucleus. The
Golgi phenotype seen in siNAA60 cells was not present
after knockdown of NAA50 (Figures 6A and 6B), the Na-acetyl-
transferase phylogenetically and enzymatically most similar to
Naa60 and also reported to have overlapping phenotypes in
Drosophila (see Introduction).
The specificity of the knockdown phenotype observed in
siNAA60-pool-treated cells was confirmed by two separate
siRNAs (Figure S4B) as well as a small hairpin RNA (shRNA) ex-
pressed from a vector containing red fluorescent protein, allow-
ing identification of transfection-positive cells (Figure S4C). The
specificity of NAA60 siRNA was also assessed by the inability
of the phNAA60-V5 (but not phNAA10-V5, phNAA30-V5, or
phNAA50-V5) plasmid to express in siNAA60-pool-treated cells
(data not shown).
Next, we tested whether the siNAA60-induced Golgi pheno-
type could be rescued by overexpression of NAA60. Since the
NAA60-V5 expression was efficiently repressed in siNAA60-
pool-treated cells, we created a new version of this plasmid,
harboring silent mutations to allow expression in the presence
of siNAA60-4 (see Experimental Procedures). Indeed, ex-
pression of this NAA60-V5, but not any of the cytosolic
Na-acetyltransferases NAA10-, NAA30-, or NAA50-V5, pre-
cludedmanifestation of a fragmentedGolgi structure (Figure 6C).
To better characterize the NAA60-knockdown Golgi pheno-
type, we co-stained siRNA-treated cells with GM130 and Man-
nosidase II (ManII). We observed these cis- and medial-Golgi
marker proteins to cohere equally well in siNAA60-treated Golgi
phenotypic cells as in siCTRL cells (Figure 6D). This observation
implies that the Golgi stack architecture remains intact, which
suggests that the Golgi fragmentation observed in siNAA60 cells
rather signifies a disruption of Golgi ribbon integrity. Further-
more, we observed three distinguishable degrees of severity of
Golgi fragmentation (Figure 6D, left toward right), possibly repre-
senting a progression from loss of longer tubular/reticular struc-
tures toward scattering of the Golgi with fragments spreading
further in the cytosol.
Finally, the structural Golgi defects inNAA60-knockdown cells
seemed to be specific for this organelle, as the localization
pattern of several different organellar markers remained unal-
tered. Here, no changes in localizations were detected for the
ER, mitochondrial, peroxisomal, endosomal, and lysosomal
markers tested (Figure S5). Also, no changes in F-actin or micro-
tubuli, such as cytoskeletal disassembly or microtubule bundles,
could be observed in siNAA60-treated cells (Figure S5).
DISCUSSION
Naa60: An Organelle-Associated NAT
In this study, we present the first organelle-bound NAT activity,
NatF (Naa60). Naa60 associates with intracellular membranes
through a C-terminal domain, and Naa60’s resistance to alkaline
extraction from membrane isolates suggests this region to be
membrane integrated. In the PROMPT- and selective membrane
permeabilization-topology assays, all tested regions of Naa60
were detected on the cytosolic face, and we were unable to
detect any lumenal parts of Naa60. The fact that both the N
Figure 6. NAA60 Knockdown Affects Golgi
Morphology
(A) Abnormal Golgi morphology was observed in
siNAA60-treated, but not siNAA50-treated, HeLa
cells immunostained for the cis-Golgi marker
GM130 and compared to siCTRL. Images are
based on cell counts showing fragmented Golgi in
14% of siCTRL (n = 338), 14% of siNAA50 (n =
263), and 38% of siNAA60 (n = 231). See also
Figure S4A for additional statistics.
(B) Reduction in mRNA level after treatment of
HeLa cells with smart pool siRNA used in (A).
NAA50,NAA60, and ACTIN PCRswere performed
on cDNA synthesized from RNA isolates from cells
treated with siCTRL, siNAA50 and siNAA60 cells
as in (A). This confirmation was performed in all
siRNA experiments.
(C) Left: the siNAA60-induced Golgi phenotype
could be rescued by Naa60-V5 expression, but
not by expressing any of the cytosolic NATs
(Naa10-, Naa30-, or Naa50-V5). Cells were treated
with siNAA60-4 and, 3–4 hr later, transfected with
V5 plasmids encoding the indicated proteins.
Naa60-V5 contained silent mutations enabling
expression in siNAA60-4-treated cells. The % of
cells displaying a fragmented Golgi was counted
among V5-positive cells only, except in the siCTRL
and the siNAA60-4 samples (bars 1 and 2). Addi-
tionally, to exclude plasmid expression efficacies
as a confounding variable, an expression control
(Naa60-low expr.) was performed where the ‘‘si-
NAA60-4 + Naa60-V5’’ condition was recounted,
only considering the weakest half of the V5-posi-
tive cell population. Right: immunofluorescence
images from the same experiment as to the left.
(D) siCTRL- and siNAA60-treated cells co-immu-
nostained for GM130 and Mannosidase II (ManII)
revealed that these cis- andmedial-Golgi markers
cohered equally well in control and Golgi pheno-
typic cells. Three differing degrees of Golgi struc-
tural effects observed in the siNAA60 cells are
shown.
All scale bars represent 10 mm. See also validating
data in Figure S4 and additional data in Figure S5.and C terminus of Naa60 faces the cytosol precludes an odd
number of TMDs. As such, Naa60 could harbor a hairpin helical
structure embedded in the membrane formed by the putative
TMD3 and 4 (refer to Figure 2A), or parts of this region could
be membrane embedded. Most importantly, these topology
data revealed the interesting characterization that even though
Naa60 is an organellar NAT, its activity is directed toward the
cytosol, which was also further corroborated by the known/pre-
dicted N-out topologies of the Naa60 substrates identified.
Our data on Naa60 targeting and topology contrast that
described by Yang and colleagues (Yang et al., 2011), whoCell Reports 10, 1362–137claimed that deletion of putative TMD1
and TMD2 (termed A and B in their
work) leaves a cytosolic Naa60 (termed
HAT4 in their work). We disagree with
the interpretation of these results. The
C-terminal truncated Naa60, used in ourstudy, shows a complete loss of the organellar localization and
is supported by the capacity of this C-terminal Naa60 region
(aa 182–242) to target eGFP to the same localization. In the
work of Yang et al., the deleted part (aa 52–103), claimed to be
transmembrane, covered a large portion of the catalytic GNAT
domain, and this is not discussed. Furthermore, we have here
established that aa 69–82, a crucial part of the GNAT domain,
faces the cytosolic side. Importantly, our finding that Naa60
Nt-acetylates cytosolic N termini of transmembrane proteins
also robustly supports the cytosolic position of the GNAT
domain.4, March 3, 2015 ª2015 The Authors 1371
The Organellar Nt-Acetylome Reveals Naa60’s
Preference for Transmembrane Proteins
Through the analysis of organelle-enriched samples, we here
establish Nt-acetylation as an abundant modification among
transmembrane proteins, thus providing new insights into this
hitherto poorly characterized part of the Nt-acetylome. By the
identification of several Naa60 substrates, we here uncovered
another distinct Naa60 feature: its clear preference for trans-
membrane proteins. As such, the apparent redundancy in the
substrate specificity profiles of NatF (Naa60), NatC (Naa30),
and NatE (Naa50) can likely be explained by Naa60’s in vivo pref-
erence for transmembrane proteins as well as by its distinct sub-
cellular distribution (Figure 1A). In line with previous data, only
partially acetylated N termini (Table 1, column 3) were affected
by the knockdown, which indicates that only partially or subopti-
mal acetylated substrateN terminiwere affected, likely as a result
of thehigh efficiencyof theNt-acetylation reaction (Arnesenet al.,
2009; VanDammeet al., 2012). Thus, overall, it is likely thatNaa60
represents the main NAT for Nt acetylation of integral membrane
proteins displaying the Naa60/NatF specificity profile.
The predominant Golgi localization of Naa60 suggests a post-
translational mode of Nt-acetylation activity as another distinct
feature of this enzyme as opposed to the established dogma
of ribosome-associated cotranslational Nt-acetylation. How-
ever, several of the substrates of Naa60-mediated acetylation
identified in this study are ER-resident proteins. The data pro-
vided here do not exclude some ER association of Naa60. In
fact, Naa60 could be targeted to the membrane by means of
the hydrophobic C-terminal stretch acting as a targeting
sequence for its cotranslational membrane insertion. Naa60
might acetylate its ER-resident substrates while passing through
this organelle on its way to the Golgi, or a subpopulation of
Naa60 molecules may permanently localize to the ER. Also,
Naa60 activity at the Golgi may act on ER proteins visiting the
Golgi prior to their retrograde sorting back to the ER. Transmem-
brane proteins of the secretory pathway with a primary localiza-
tion post-Golgi could be acetylated by small Naa60 populations
in those compartments, or by Golgi-residing Naa60 while the
substrates are transported through the Golgi apparatus.
Should Naa60 have cotranslational activity, it might be consid-
ered to have a connection to ER translocation complexes. In this
regard, it is interesting that the protein found to be most affected
in its Nt-acetylation status by NAA60 knockdown was TRAPg,
which constitutes part of the TRAP complex that aids cotransla-
tional translocation of some proteins. It has previously been
shown that Sec-complex subunits Sec61, Sec62, and Sbh1
are cotranslationally Nt-acetylated by NatA in yeast and that
the Nt-acetyl group is not essential for their co- or posttransla-
tional translocation (Soromani et al., 2012).
Others have previously described connections between Nt-
acetylation and ER translocation. Forte and colleagues (Forte
et al., 2011) found that cytosolic proteins were more likely to
have Nt-acetylation-prone N termini compared to proteins
destined for secretion. They showed that mutating secretory
signal sequences of posttranslationally targeted proteins into
acetylation-prone N termini resulted in their cytosolic retention.
Signal recognition particle (SRP)-dependent cotranslational
translocation, on the other hand, tolerated NAT substrate N1372 Cell Reports 10, 1362–1374, March 3, 2015 ª2015 The Authorstermini. However, although compatible with Nt-acetylation, pro-
teins targeted to the ER by the SRP pathway were usually not
modified (Forte et al., 2011). In this aspect, it is of note that our
N-terminal COFRADIC analyses showed that the degree of Nt
acetylation was typically lower for integral membrane proteins
as compared to their soluble counterparts displaying identical
N-terminal residues at the first two positions. This may provide
support to the data presented by Forte and colleagues (Forte
et al., 2011), or it may suggest that cotranslational membrane
integration of nascent proteins affects the overall extent of Nt-
acetylation. These trends cannot be too widely generalized, as
several examples exist where Nt-acetylation of transmembrane
and tail-anchored proteins does not preclude their targeting to
the ER, like the abovementioned Sec-complex subunits and
also the Naa60 substrates reported here. As discussed by Soro-
mani and colleagues (Soromani et al., 2012), Nt-acetylation
might interfere with posttranslational ER targeting only via the
Sec63 complex.
Naa60 Localizes to the Golgi and Is Essential for Golgi
Ribbon Integrity
We found here not only that Naa60 localizes to the Golgi but also
that NAA60 knockdown induces Golgi fragmentation. This frag-
mentation likely reflects disruption of the Golgi ribbon. The Golgi
ribbon is normally composed of lateral tubular interconnection of
stacks. Since cis- andmedial-Golgi markers co-distributed in si-
NAA60 phenotypic cells, the data indicate that the structural ef-
fect observed signifies a fragmentation of the Golgi ribbon into
unlinked—but still clustered—stacks. Thus, we consider ribbon
unlinking (disrupted interactions between adjacent stacks) as a
more plausible explanation for the Golgi structural phenotype
rather than unstacking of cis-,medial-, and trans-compartments
of the Golgi. Combined with the finding that Naa60 Nt-acetylates
transmembrane proteins, it is likely that Nt-acetylation of one
or more transmembrane Naa60 substrate proteins is involved,
either directly or indirectly, inGolgi ribbon structural organization.
The substrate proteins identified here likely represent a small
subset of the total Naa60 repertoire. Thus, Golgi-residing pro-
teins or transport proteins important for Golgi structural integrity
that display a Naa60/NatF-type substrate profile could be inter-
esting subjects for future follow-up studies. Alternatively, the
Golgi fragmentation might be related to possible cytoskeletal-
related effects, as both the microtubule and the actin cytoskel-
eton play important roles in the maintenance and regulation of
the Golgi’s structure (Egea et al., 2006; Thyberg and Moskalew-
ski, 1999). Although no cytoskeletal disruptionswere observed in
Naa60-depleted cells, other cytoskeleton regulators/interactors
or motor proteins could be affected in the absence of Naa60-
mediated Nt-acetylation.
Golgi fragmentation occurs in a regulated fashion during both
mitosis and apoptosis. The likelihood of the latter being the sole
cause of the phenotype described here is strongly reduced by
the use of the caspase inhibitor Z-VAD and by the p53-dysfunc-
tional CAL-62 cells, as well as by the maintained structural integ-
rity of other organelles known to undergo structural disassembly
during apoptosis. However, in mitosis, the mammalian Golgi
apparatus undergoes vast stepwise structural reorganization,
starting with mitotic ribbon unlinking. Interestingly, the integrity
of the Golgi ribbon is also suggested to be linked to a G2/M cell-
cycle checkpoint (Rabouille and Kondylis, 2007). Thus, the Golgi
phenotype observed here in Naa60-depleted HeLa cells may be
linked to the chromosome-lagging phenotype described in
Naa60-depleted Drosophila cells, where Naa60 was suggested
to be important for normal chromosome segregation during
anaphase progression (Van Damme et al., 2011b).
In conclusion, this work characterizes Naa60 as the first re-
ported membrane-associated NAT. Naa60 specifically acety-
lates cytosolic N termini of transmembrane proteins and is
important for Golgi ribbon integrity. As we have also shown Nt-
acetylation to be a commonmodification amongmembrane pro-
teins, we propose that Naa60 is necessary for maintenance of
the Golgi ribbon through its Nt-acetylation of substrate protein(s)
that is/are involved in Golgi ribbon structural and/or functional
organization.
EXPERIMENTAL PROCEDURES
HeLa, HeLaS3, A-431, and 293 cells were transfected with Fugene 6 (Roche/
Promega), X-tremeGENE 9 (Roche), or Effectene (PROMPT validation experi-
ments) according to the manufacturer’s protocol. 0.25–0.5 mg DNA was used
per ml culture medium. Unless otherwise indicated, cells were used for down-
stream experiments 12–24 hr posttransfection. NAA60 knockdown was per-
formed by transfection using Dharmafect 1 (GE Dharmacon) or HiPerFect
(QIAGEN) according to the respectivemanufacturer’s protocols, with the addi-
tion of 5 nM pan-caspase inhibitor Z-VAD-FMK (renewed every 24 hr by
replacing half of the culture medium). Cells were harvested or fixed approxi-
mately 72 or 96 hr post-siRNA transfection. Further cell culture details andma-
terial specifications on siRNA and shRNA are provided in the Supplemental
Experimental Procedures.
For preparation of crude A-431 cell fractions, cells were harvested and dis-
solved in homogenization buffer (0.25M sucrose, 1mMEDTA, 20mMHEPES-
NaOH [pH 7.4]), after which nuclei were removed by sedimentation at 3,0003
g for 5 min and organelles and cytosol were separated by centrifugation at
17,000 3 g for 20 min. SILAC-labeled fractionated A-431 cells were used for
N-terminal COFRADIC analysis, as previously described (Staes et al., 2011;
Van Damme et al., 2009) and detailed in the Supplemental Experimental
Procedures.
Standard procedures were followed for immunocytochemistry, and the
buffers, antibodies, and incubation times are given in detail in the Supple-
mental Experimental Procedures. Fluorescent images in Figures 3B, 6A, and
6D were obtained on a Leica TCS SP2 AOBS. Fluorescent images in Figures
6A and 6D were obtained on z stacks of 0.2- to 0.3-mm-thick optical sections
spanning the entire depth of Golgi complexes and are shown as maximum-in-
tensity projections, and insets are presented as projections of two or three
successive sections. All other fluorescent images were obtained on a Leica
DMI6000 B wide field microscope. Further instrument details can be found
in the Supplemental Experimental Procedures. The acquired images were pro-
cessed using the Photoshop CS5 image software (Adobe Systems).
Detailed information on additional procedures, including bioinformatics
tools used and construction of plasmids, are available in the Supplemental
Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and two tables and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2015.01.053.
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